MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Depression"

  • 2024 International Congress

    Efficacy of Audiovisual Neuromodulation in the Treatment of Parkinson’s Disease

    O. Alenikova, L. Parkhach, E. Bоsiakova, G. Zobnina (Minsk, Belarus)

    Objective: To evaluate the AVS effectiveness in depression, anxiety, autonomic disorders and visual dysfunction in PD patients. Background: The severity of non-motor dopa-resistant symptoms in…
  • 2024 International Congress

    Neurophysiological Underpinnings of Apathy in Parkinson’s Disease Versus Depressive Disorders: A Comparative Study

    D. Nolasco, A. Sohel, B. Carr (Gainesville, USA)

    Objective: The manifestation of apathy in neurological and psychiatric conditions such as Parkinson's Disease (PD) and depressive disorders presents a significant clinical challenge. This study…
  • 2024 International Congress

    Effect Of Botulinum Toxin On Non-Motor Symptoms In Adult-Onset Idiopathic Focal Dystonia

    S. Mehta, R. Gupta, N. Balaini, S. Grover, V. Lal (Chandigarh, India)

    Objective: To assess the effect of Botulinum toxin on non-motor symptoms and quality of life in patients with adult-onset idiopathic focal dystonia. Background: A broad…
  • 2024 International Congress

    Listening to the Insight: The Underdiagnosis of Depression in People Living with Parkinson’s Disease

    G. Rivera-Monroy, RJ. Baños-Betancourt, K. Velázquez-Román, CF. álvarez-Hernández, AL. Guerra-Anzaldo, WF. Moguel-Cardín, A. Domínguez-García, MF. Medina-Pérez, JC. Delgado-Uriarte, NP. Moreno-Aldama, A. Uribe-León, MC. Unda-Mcfarlane, AJ. Hernández-Medrano, A. Cervantes-Arriaga, M. Rodríguez-Violante (Mexico City, Mexico)

    Objective: To determine the prevalence of risk of undiagnosed depression among people living with Parkinson's disease (PwP) without a prior depression diagnosis. Background: Parkinson's disease…
  • 2024 International Congress

    Clinical and Epidemiological Aspects of Neuropsychiatric Features in Patients with Huntington Disease in Chile

    J. Fuentes, P. Salles, P. Chaná-Cuevas, C. Montalva, M. Sánchez, N. Rojas (Santiago, Chile)

    Objective: To describe the prevalence of motor and neuropsychiatric symptoms in HD patients seen at the Center of Movement Disorders (CETRAM), Santiago, Chile. Background: There…
  • 2023 International Congress

    Identifying prodromal NMS in a population-based recruitment strategy: Kassel data of Healthy Brain Ageing

    S. Schade, C. Vega Moreno, C. Horlings, A. Garrido, T. Marques, P. Mahlknecht, E. Bryan, C. Gomes, C. Pauly, S. Ghosh, K. Rege, R. Rawal, T. Wicke, E. Lang, S. Schnell, V. Satagopam, K. Seppi, M. Marti, E. Tolosa, W. Poewe, R. Krüger, C. Trenkwalder, B. Mollenhauer (Kassel, Germany)

    Objective: To identify subjects with NMS for recruitment of a cohort at risk for prodromal PD Background: Neurodegeneration in PD starts years before the development…
  • 2023 International Congress

    Monoamine loss and depression in Parkinson’s disease: a PET study

    BL. Xu, XL. Liu, SY. Liu, O. Barret, G. Tamagnan, H. Qiao, TB. Song, J. Lu, P. Chan (Beijing, China)

    Objective: 1)To evaluate the imaging manifestations of monoamine changes in PD patients with depression through 18F-FP-DTBZ PET; 2) To explore the relationship between monoamine changes…
  • 2023 International Congress

    Longitudinal assessment of evolution and plasma biomarkers for depression and anxiety in Parkinson’s disease

    J. Lin, R. Ou, C. Li, Q. Wei, Y. Hou, L. Zhang, K. Liu, Q. Jiang, T. Yang, Y. Xiao, D. Pang, Y. Yu, B. Zhao, X. Chen, W. Song, J. Yang, Y. Wu, H. Shang (Chengdu, China)

    Objective: We aimed to investigatethe evolution of depression and anxietyin a large Parkinson's disease (PD) cohort and explore the related plasma biomarkers. Background: Depression and anxietyare common non-motor…
  • 2023 International Congress

    Hazard ratios of suicidality in a large Huntington disease population compared with controls: marginal structural modeling of Enroll-HD registry data

    S. Reshef, V. Sung, G. Smith, O. Harari, D. Zhang, M. Forrest Gordon, R. Willock, R. Ribalov, J. Robles-Zurita, E. Furr Stimming (Parsippany-Troy Hills, USA)

    Objective: The aim of this study was to describe the risk of suicidality among individuals with versus those without Huntington disease (HD) from Enroll-HD. Background:…
  • 2023 International Congress

    Depression in Parkinson’s disease is associated with subcortical neurodegeneration and increased risk of all-cause mortality and dementia

    J. Badenoch, A. Paris, B. Jacobs, A. Noyce, C. Marshall, S. Waters (London, United Kingdom)

    Objective: To evaluate the temporality, neuroanatomical correlates and prognostic significance of depression in PD using a large population cohort. Background: Depression may be an important…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 32
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Patients with Essential Tremor Live Longer than their Relatives
  • #23624 (not found)
  • The hardest symptoms that bother patients with Parkinson's disease
  • Three cases of early tremor in the course of Guillain-Barré Syndrome
  • The impact of gastric acid suppressants and antacids on levodopa plasma concentration in patients with Parkinson’s disease
  • To be or not to bupropion: a drug-induced parkinsonism?
  • The Role of MRI and DaTscan in Vascular Parkinsonism: A Case Report
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley